Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

Almirall - 2025" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into the Almirall's tech activities, including its digital transformation strategies, ...

Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.

HONG KONG, China I April 18, 2025 I Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal ...

Patients with plaque psoriasis treated with Johnson & Johnson’s oral IL-23 inhibitor JNJ-2113 have been shown to maintain skin clearance for up to a year, pointing to a durable effect for a drug ...

THOUGHT you’d nailed your beauty regime? Even if you’re using all the right products, you might still be damaging your health ...

which is found in high concentrations in skin affected by psoriasis. Cosentyx has also been approved in Australia for the treatment of moderate-to-severe plaque psoriasis and in Japan for the ...

After falling 17 per cent since the start of the year to its March lows, the stock of the country's largest pharmaceutical ...